[1]谢安,肖和平.环丝氨酸在治疗耐多药结核病方面的应用.中华结核和呼吸杂志,2012,35(12):949-950.[2]Falzon D,Jaramillo E,Schünemann HJ,et al.WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J,2011,38(3):516-528.[3]Masjedi MR,Tabarsi P,Chitsaz E,et al.Outeome of treatment of MDR-TB patients with standardised regimens,Iran,2002—2006.Int J Tuberc Lung Dis,2008,12(7):750-755.[4]Escudero E, Pena JM,Alvarez-Sala R,et al.Multidrug-resistant tuberculosis without HIV infection:success with individualised therapy.Int J Tuberc Lung Dis,2006,10(4):409-414.[5]中国防痨协会.耐药结核病化学治疗指南(2009).中国防痨杂志,2010,32(4):181-198.[6]缪昌东, 姜继军.环丝氨酸致精神异常一例. 中国防痨杂志,2013,35(6):480-480.[7]World Health Organization. Management of MDR-TB:a field guide-a companion document to guidelines for the program-matic management of drug-resistant tuberculosis. Geneva: World Health Organization,2008: 20.[8]宋艳华,郭少晨,高孟秋,等.环丝氨酸治疗耐多药结核病的血药浓度及不良反应监测.中国防痨杂志, 2014,36(5): 399-401. |